Literature DB >> 2954268

Establishment of five human malignant non-T lymphoid cell lines and mixed lymphocyte-tumor reaction.

M Minegishi, S Tsuchiya, N Minegishi, T Konno.   

Abstract

Five human malignant non-T lymphoid cell lines have been established. THP-4 and THP-7 were derived from two children with common type acute lymphoblastic leukemia (ALL), THP-6 and THP-8 from two children with null cell type ALL and THP-9 from a child with malignant lymphoma. THP-4 was positive for cytoplasmic mu, B4, common ALL antigen (CALLA) and Ia-like antigen (Ia), THP-7 positive for B4, CALLA and Ia, THP-8 positive for B4 and Ia, and THP-9 positive for surface mu-lambda, B1, B4, CALLA and Ia. No antigenic determinants for monoclonal antibodies used were detected on THP-6. THP-4, THP-7, THP-8 and THP-9 were able to stimulate allogeneic lymphocytes vigorously. THP-6 without Ia stimulated not only allogeneic lymphocytes, but also autologous ones. THP-7 did not stimulate autologous lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2954268     DOI: 10.1620/tjem.151.283

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  5 in total

1.  Copy number abnormality of acute lymphoblastic leukemia cell lines based on their genetic subtypes.

Authors:  Chihiro Tomoyasu; Toshihiko Imamura; Toshihiro Tomii; Mio Yano; Daisuke Asai; Hiroaki Goto; Akira Shimada; Masashi Sanada; Shotaro Iwamoto; Junko Takita; Masayoshi Minegishi; Takeshi Inukai; Kanji Sugita; Hajime Hosoi
Journal:  Int J Hematol       Date:  2018-05-21       Impact factor: 2.490

2.  Anti-leukemic activity of bortezomib and carfilzomib on B-cell precursor ALL cell lines.

Authors:  Kazuya Takahashi; Takeshi Inukai; Toshihiko Imamura; Mio Yano; Chihiro Tomoyasu; David M Lucas; Atsushi Nemoto; Hiroki Sato; Meixian Huang; Masako Abe; Keiko Kagami; Tamao Shinohara; Atsushi Watanabe; Shinpei Somazu; Hiroko Oshiro; Koshi Akahane; Kumiko Goi; Jiro Kikuchi; Yusuke Furukawa; Hiroaki Goto; Masayoshi Minegishi; Shotaro Iwamoto; Kanji Sugita
Journal:  PLoS One       Date:  2017-12-13       Impact factor: 3.240

3.  NUDT15 polymorphism and NT5C2 and PRPS1 mutations influence thiopurine sensitivity in acute lymphoblastic leukaemia cells.

Authors:  Shinpei Somazu; Yoichi Tanaka; Minori Tamai; Atsushi Watanabe; Keiko Kagami; Masako Abe; Daisuke Harama; Tamao Shinohara; Koshi Akahane; Kumiko Goi; Kanji Sugita; Takaya Moriyama; Jun Yang; Hiroaki Goto; Masayoshi Minegishi; Shotaro Iwamoto; Junko Takita; Takeshi Inukai
Journal:  J Cell Mol Med       Date:  2021-10-12       Impact factor: 5.310

4.  Clofarabine exerts antileukemic activity against cytarabine-resistant B-cell precursor acute lymphoblastic leukemia with low deoxycytidine kinase expression.

Authors:  Meixian Huang; Takeshi Inukai; Kunio Miyake; Yoichi Tanaka; Keiko Kagami; Masako Abe; Hiroaki Goto; Masayoshi Minegishi; Shotaro Iwamoto; Eiji Sugihara; Atsushi Watanabe; Shinpei Somazu; Tamao Shinohara; Hiroko Oshiro; Koshi Akahane; Kumiko Goi; Kanji Sugita
Journal:  Cancer Med       Date:  2018-02-23       Impact factor: 4.452

5.  Inherited genetic variants associated with glucocorticoid sensitivity in leukaemia cells.

Authors:  Tamao Shinohara; Kevin Y Urayama; Atsushi Watanabe; Koshi Akahane; Kumiko Goi; Meixian Huang; Keiko Kagami; Masako Abe; Kanji Sugita; Yukinori Okada; Hiroaki Goto; Masayoshi Minegishi; Shotaro Iwamoto; Takeshi Inukai
Journal:  J Cell Mol Med       Date:  2020-10-01       Impact factor: 5.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.